INTERVIEW WITH Martina Perharič, Medis CEO
We All Deserve the Same Treatment Options
Ähnliche Neuigkeiten
Upcoming Changes in Medis Leadership
Martina Perharič, the current CEO of Medis, will transition to a new role as Chief Business Officer (CBO) of Pharmaceuticals, effective 1 August 2023. At the...
Lesen Sie mehr
Combining Forces to Reach Patients with Rare Diseases Across the Globe
World Orphan Drug Alliance (WODA) is a new global alliance of full-service regional distributors for orphan drugs.
Lesen Sie mehr